T. Romigh

发表

Neural transcriptome of constitutional Pten dysfunction in

C. Eng, G. Bebek, A. Tilot, 2015 .

Enhanced Proteasome Activity Cowden Syndrome-Related Mutations in PTEN

C. Eng, T. Romigh, Xin He, 2013 .

Companion Diagnostics and Cancer Biomarkers Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ 235 ' s Therapeutic Effect Mediated by PTEN and KLLN Upregulation

C. Eng, J. Altemus, T. Romigh, 2014 .

Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation

C. Eng, J. Altemus, T. Romigh, 2013, Molecular Cancer Therapeutics.

PTEN modulates gene transcription by redistributing genome-wide RNA polymerase II occupancy

C. Eng, T. Romigh, Roshan Padmanabhan, 2019, Human molecular genetics.

Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits

C. Eng, T. Frazier, T. Romigh, 2015, Molecular Autism.

PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain

C. Eng, T. Romigh, Ata Abbas, 2019, Oncotarget.

Nuclear PTEN levels and G2 progression in melanoma cells

C. Eng, K. Waite, T. Romigh, 2009, Melanoma research.

PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.

C. Eng, M. Saji, M. Ringel, 2012, The Journal of clinical endocrinology and metabolism.

AP-2α Induces Epigenetic Silencing of Tumor Suppressive Genes and Microsatellite Instability in Head and Neck Squamous Cell Carcinoma

C. Eng, T. Romigh, Kristi L. Bennett, 2009, PloS one.

Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53

C. Eng, T. Romigh, Xin He, 2010, Human molecular genetics.

Activator protein 2 alpha (AP2α) suppresses 42 kDa C/CAAT enhancer binding protein α (p42C/EBPα) in head and neck squamous cell carcinoma

C. Plass, C. Eng, T. Romigh, 2009, International journal of cancer.

The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation.

Michael C. Ostrowski, C. Eng, M. Ostrowski, 2006, Human molecular genetics.

Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production.

C. Eng, A. Tilot, T. Frazier, 2014, Human molecular genetics.

Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic Autism Spectrum Disorder

C. Eng, G. Bebek, A. Tilot, 2015, Molecular Psychiatry.

Redefining the PTEN promoter: Identification of novel upstream transcription start regions.

C. Eng, T. Romigh, D. Luse, 2021, Human molecular genetics.

Strain-specific variants of the mouse Cftr promoter region reveal transcriptional regulatory elements.

M. Drumm, T. Romigh, S. Satinover, 2004, Human molecular genetics.

Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.

C. Eng, T. Romigh, Kristi L. Bennett, 2009, Cancer research.

Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.

S. Meltzer, C. Eng, G. Bebek, 2011, JAMA.

Germline Mutations in MSR 1 , ASCC 1 , and CTHRC 1 in Patients With Barrett Esophagus and Esophageal Adenocarcinoma

Cgc, S. Meltzer, C. Eng, 2011 .

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines

R. Silverman, C. Eng, T. Romigh, 2010, Human molecular genetics.

Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.

C. Eng, T. Romigh, J. Mester, 2012, The Journal of clinical endocrinology and metabolism.

Redefining the PTEN Promoter: Identification of Two Upstream Transcription Start Regions

C. Eng, T. Romigh, D. Luse, 2021, bioRxiv.

ATP modulates PTEN subcellular localization in multiple cancer cell lines

C. Eng, J. Houghton, S. Planchon, 2008, Human molecular genetics.

Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function

C. Eng, S. Planchon, K. Waite, 2009, Human molecular genetics.

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers

R. Silverman, C. Eng, M. Tan, 2011, Oncogene.

Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome

Charis Eng, C. Eng, T. Romigh, 2017, Human mutation.

Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity.

C. Eng, T. Romigh, Xin He, 2013, Cancer research.

Exome Sequencing Reveals Germline SMAD9 Mutation That Reduces Phosphatase and Tensin Homolog Expression and Is Associated With Hamartomatous Polyposis and Gastrointestinal Ganglioneuromas.

L. Tucker-Kellogg, C. Eng, Haiwei Song, 2015, Gastroenterology.

Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma

T. LaFramboise, C. Eng, M. Saji, 2016, Human molecular genetics.

Erratum to: Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits

C. Eng, T. Frazier, T. Romigh, 2016, Molecular Autism.

SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole

Alice Hooper, C. Goins, T. Romigh, 2023, Medicinal Chemistry Research.